Wilsonville, OR, United States of America

Roderic M Dale



Average Co-Inventor Count = 1.9

ph-index = 3

Forward Citations = 243(Granted Patents)


Company Filing History:

goldMedal3 out of 12 
 
Oligos Etc. Inc.
 patents
silverMedal1 out of 21 
 
Chemgenes Corporation
 patents
bronzeMedal1 out of 832,718 
Other
 patents
where one patent can have more than one assignee

Years Active: 1999-2000

Loading Chart...
Loading Chart...
3 patents (USPTO):Explore Patents

Title: Roderic M Dale: Innovator in Oligonucleotide Technologies

Introduction

Roderic M Dale is a notable inventor based in Wilsonville, OR (US), recognized for his contributions to the field of oligonucleotide technologies. With a total of three patents to his name, Dale has made significant advancements that enhance the efficacy of synthetic oligonucleotides in therapeutic applications.

Latest Patents

Dale's latest patents include innovative technologies such as "Arrays with modified oligonucleotide and polynucleotide compositions." This invention provides arrays that feature modified oligonucleotides, specifically 2'-O-R oligonucleotides. These arrays are designed to exhibit increased binding affinity with complementary nucleic acids, particularly RNA. Additionally, the associated nucleic acids demonstrate substantial acid resistance, allowing treatment with low pH solutions, and exhibit resistance to nuclease degradation. Another significant patent is related to "Oligonucleotide phosphate esters," which focuses on synthetic oligonucleotides that have modifications in the sugar phosphate backbone, enhancing their antisense properties for therapeutic applications.

Career Highlights

Throughout his career, Roderic M Dale has worked with various companies, including Oligos Etc. Inc. and Chemgenes Corporation. His work in these organizations has contributed to the development of cutting-edge oligonucleotide technologies that are vital for research and therapeutic applications.

Collaborations

Dale has collaborated with notable professionals in his field, including Amy Arrow and Suresh C Srivastava. These collaborations have likely enriched his research and development efforts, leading to innovative solutions in oligonucleotide technology.

Conclusion

Roderic M Dale's contributions to the field of oligonucleotide technologies through his patents and collaborations highlight his role as a significant innovator. His work continues to influence advancements in therapeutic applications, showcasing the importance of innovation in science and technology.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…